Strauss, L., Weaver, J. D., Pal, R., Asara, J., Patsoukis, N., & Boussiotis, V. A. (2018). Metabolic Reprogramming of Myeloid Cells in Response to Factors of “Emergency” Myelopoiesis By Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate Commitment and Anti-Tumor Immunity. Blood, 132(Supplement 1), 14. https://doi.org/10.1182/blood-2018-99-117438
Chicago Style (17th ed.) CitationStrauss, Laura, Jessica D. Weaver, Rinku Pal, John Asara, Nikolaos Patsoukis, and Vassiliki A. Boussiotis. "Metabolic Reprogramming of Myeloid Cells in Response to Factors of “Emergency” Myelopoiesis By Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate Commitment and Anti-Tumor Immunity." Blood 132, no. Supplement 1 (2018): 14. https://doi.org/10.1182/blood-2018-99-117438.
MLA (9th ed.) CitationStrauss, Laura, et al. "Metabolic Reprogramming of Myeloid Cells in Response to Factors of “Emergency” Myelopoiesis By Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate Commitment and Anti-Tumor Immunity." Blood, vol. 132, no. Supplement 1, 2018, p. 14, https://doi.org/10.1182/blood-2018-99-117438.